My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2018-015A1
CBCC
>
Official Documents
>
2010's
>
2018
>
2018-015A1
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
12/21/2020 11:37:35 AM
Creation date
5/9/2018 1:10:52 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Agreement
Approved Date
01/23/2018
Control Number
2018-015A1
Agenda Item Number
12.D.1.
Entity Name
RxBenefits
Subject
Administrative Services Agreement for Prescription Benefits
Alternate Name
Health Insurance Drug Benefits
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
38
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
"Member Submitted Claim" means a paper claim submitted by a Member for Covered Drugs dispensed by a <br />pharmacy for which the Member paid cash. <br />"Pass -Through" means the actual ingredient cost and dispensing fee amount paid by ESI for the Prescription <br />Drug Claim when the claim is adjudicated to the Participating Pharmacy, as set forth in the specific <br />Participating Pharmacy remittances related to Client's claims. <br />"PDL" means the PBM Performance Drug List, which is a list of preferred pharmaceutical products, created <br />and maintained by PBM, as amended from time to time, which: (a) has been approved by PBM's pharmacy <br />and therapeutics committee; and (b) reflects PBM's recommendations as to which pharmaceutical products <br />should be given favorable consideration by plans and their participants. <br />"Participating Pharmacy" means any licensed retail pharmacy with which ESI or one or more of its affiliates <br />has executed an agreement to provide Covered Drugs to Members but shall not include any mail order or <br />specialty pharmacy affiliated with any such Participating Pharmacy. Participating Pharmacies are <br />independent contractors of ESI. <br />"Plan" means the self-funded prescription drug benefit plan(s) administered and/or sponsored by Client. <br />"Plan Administrator" means the Plan sponsor or committee designated by the Plan sponsor with respect to <br />the Plan, as contemplated by Section 3 (16)(A) of ERISA. <br />"Plan Design" means drug coverage, days' supply limitation, Cost Share, Formulary (including Formulary <br />drug selection and relative cost indication) and other Prescription Drug Program specifications applicable to <br />the Prescription Drug Program designated for Client as set forth in this Agreement or otherwise documented <br />between the Parties. <br />"PMPM" means per Member per month fee, if applicable, as determined by Administrator from the <br />Eligibility Files. <br />"Prescription Drug Claim" means a Member Submitted Claim, Subrogation Claim or claim for payment <br />submitted to ESI by a Participating Pharmacy, Mail Service Pharmacy or ESI Specialty Pharmacy as a result <br />of dispensing Covered Drugs to a Member. <br />"Prescription Drug Program" means the specific pharmacy benefit management services and benefit design <br />adopted by, and applicable to, Client under this Agreement. <br />"Primary Member" means each Member, excluding Members who are qualified dependents. <br />"Protected Health Information" or "PHI" shall have the meaning given such term by HIPAA but limited to <br />that information created or received by PBM in its capacity as a subcontractor to Administrator or by <br />Administrator in its capacity as a business associate to the Plan. <br />"Rebates" mean retrospective formulary rebates that are paid to ESI pursuant to the terms of a formulary <br />rebate contract negotiated independently by ESI with a pharmaceutical manufacturer and directly attributable <br />to the utilization of certain Covered Drugs by Members. Rebates do not include Manufacturer Administrative <br />Fees; product discounts or fees related to the procurement of prescription drug inventories, ESI Specialty <br />Pharmacy or the Mail Service Pharmacy; fees received by ESI from pharmaceutical manufacturers for care <br />management or other services provided in connection with the dispensing ofproducts; or other fee-for-service <br />arrangements whereby pharmaceutical manufacturers generally report the fees paid to ESI or its affiliates for <br />services rendered as "bona fide service fees" pursuant to federal laws and regulations (collectively, "Other <br />Pharma Revenue"). Such laws and regulations, as well as ESI's contracts with pharmaceutical <br />manufacturers, generally prohibit ESI from sharing any such "bona fide service fees" earned by ESI, whether <br />wholly or in part, with any ESI client. ESI represents and warrants that it will not enter into any agreement <br />with a pharmaceutical manufacturer for Other Pharma Revenue with the intent to reduce Rebates. <br />NOT FOR DISTRIBUTION. THE INFORMATION CONTAINED HEREIN IS CONFIDENTIAL, PROPRIETARY <br />AND CONSTITUTES TRADE SECRETS OF ESI AND RXBENEFITS <br />4 <br />
The URL can be used to link to this page
Your browser does not support the video tag.